Evidence map›Paper›PMID 40447719›Full record

ArticleScientific reports2025

A critical role for IL-21/IL-21 receptor signaling in isoproterenol-induced cardiac remodeling.

Bing Qi, Ruohang Xu, Yanye Jin, Yufei Wang, Tianwei Cheng, Chang Liu, Yujin Ji, Lihong Guo, Jing Li, Yang Gao and 7 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Bing QiDepartment of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin, 300071, China.
Ruohang XuDepartment of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin, 300071, China.
Yanye JinDepartment of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin, 300071, China.
Yufei WangDepartment of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin, 300071, China.
Tianwei ChengDepartment of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin, 300071, China.
Chang LiuDepartment of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin, 300071, China.
Yujin JiDepartment of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin, 300071, China.
Lihong GuoInstitute of Digestive Disease, Shengli Oilfield Central Hospital, Dongying, 257000, China.
Jing LiDepartment of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin, 300071, China.
Yang GaoDepartment of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin, 300071, China.
Yang XuDepartment of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin, 300071, China.
Jianlin CuiDepartment of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin, 300071, China.
Jie LiuDepartment of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin, 300071, China.
Zecheng JiangDepartment of Biology, Temple University, Philadelphia, PA, 19122, USA. zecheng.jiang@temple.edu.
Lifeng FengDepartment of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin, 300071, China. 9820220108@nankai.edu.cn.
Zhi QiDepartment of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin, 300071, China. qizhi@nankai.edu.cn.
Liang YangDepartment of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin, 300071, China. yangliang@nankai.edu.cn.

Funding

China Postdoctoral Science Foundation 2023M731807NanKai University Eye Institute NKYKK202201National Natural Science Foundation of China 32071263National Natural Science Foundation of China 32271327National Natural Science Foundation of China 32301071National Natural Science Foundation of China 82072187National Natural Science Foundation of China 82172170National Natural Science Foundation of China 82372195Tianjin Natural Science Foundation 23JCQNJC01820
6 · The paper itself

Abstract

Increased cytokine secretion from immune cells is often associated with cardiac remodeling and heart failure due to pressure overload. Several reports suggest that the IL-21/IL-21 receptor (IL-21R) signaling pathway may play a critical role in heart failure progression, but the exact mechanism remains unclear. In this study, isoproterenol (ISO) was used to induce heart failure in mice and found that ISO injection caused significant upregulation of IL-21 and the IL-21R in the heart of mice. Subsequently, IL-21 receptor-deficient (IL-21R

Indexed as

Heart FailureInterleukinsIsoproterenolReceptors, Interleukin-21Signal TransductionVentricular RemodelingAnimalsApoptosisCardiomegalyCD4-Positive T-LymphocytesInterleukin-21MaleMiceMice, Inbred C57BLMice, KnockoutMyocardiumInterleukin-21InterleukinsIsoproterenolReceptors, Interleukin-21Cardiac hypertrophyIL-21STAT3

Identifiers

PMID40447719
PMCPMC12125357

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.